Filter
414
Filtered Results: 414
Text search:
American
Society
of
Microbiology
Featured
Recommendations
49
New Publications
75
Language
Document type
No document type
157
Guidelines
102
Studies & Reports
96
Manuals
27
Strategic & Response Plan
11
Training Material
8
Fact sheets
7
Situation Updates
4
Resource Platforms
1
Online Courses
1
Countries / Regions
Western and Central Europe
17
India
16
Global
15
South Africa
15
Africa
11
Latin America and the Carribbean
10
Germany
8
Philippines
7
Nigeria
6
Tanzania
6
Ethiopia
6
Sierra Leone
5
Mozambique
5
Congo, Democratic Republic of
5
Argentina
5
Russia
5
Colombia
4
Kenya
4
Burkina Faso
4
Brazil
4
Nepal
3
Ghana
3
Senegal
3
Malawi
3
Eastern Europe and Central Asia
3
Spain
3
Eastern Europe
3
Zambia
3
Thailand
2
Cameroon
2
Syria
2
Zimbabwe
2
Guinea
2
Asia
2
Venezuela
2
Middle East and North Africa
2
South–East Asia Region
2
Côte d’Ivoire / Ivory Coast
2
Uganda
2
Namibia
2
Yemen
2
Mali
2
Angola
2
South Sudan
2
Indonesia
2
Liberia
2
North Macedonia
1
Tajikistan
1
Australia
1
China
1
Chile
1
Estonia
1
Niger
1
Afghanistan
1
Burundi
1
Malaysia
1
Qatar
1
Haiti
1
Guinea-Bissau
1
Jordan
1
Western Pacific Region
1
Paraguay
1
North America
1
Belgium
1
East and Southern Africa
1
Bolivia
1
Lebanon
1
Bangladesh
1
Romania
1
Botswana
1
Ecuador
1
Madagascar
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Countries
103
Clinical Guidelines
57
Key Resources
31
Public Health
19
Pharmacy & Technologies
14
Women & Child Health
11
Capacity Building
6
Toolboxes
AMR
84
TB
62
COVID-19
49
Rapid Response
28
NTDs
21
Planetary Health
20
HIV
18
Pharmacy
13
Ebola & Marburg
12
Caregiver
10
Cholera
8
Natural Hazards
5
Mental Health
4
NCDs
4
Conflict
4
Global Health Education
4
Zika
2
Specific Hazards
1
Refugee
1
Disability
1
Health Financing Toolbox
1
Polio
1
The era of effective antibiotics is coming to a close. In just a few generations, many “miracle medicines”have been beaten into ineffectiveness by the bacteria they were intended to eradicate. Bacteria quickly adapt to the presence of antibacterial agents in order ...
The occurrence of a high percentage of couterfeit medicines on the global medicines market is often attributed to a lack of effective regulation and a weak enforcement capacity. This review, while focusing on counterfeit medicines and medical devices in developing countries, will present information...
The global emergence of antimicrobial resistance (AMR) is posing a threat to human health. Putting resources into the containment of AMR – including surveillance – is one of the highest-yield investments a country can make to mitigate its impact. In 2015, WHO launched the Global Antimicrobial Re...
The purpose of the landscape analysis is ultimately to facilitate improved engagement of private providers, thereby contributing to universal access to quality and affordable TB care and the end of the TB epidemic. It focuses on the role of private for-profit providers and on specific challenges and...
Burden of T. solium: Neurocysticercosis is a disease induced by T. solium larvae penetrating human tissues, especially the nervous system. Neurocysticercosis burdens economies, societies and individuals because of the impact of epilepsy on wages, health costs and social stigmatization of sufferers. ...
Rreport of a WHO Consultative Meeting Kolkata India 2012
Cases of monkeypox (MPX) acquired in the EU have recently been reported in nine EU Member States (Austria, Belgium, France, Germany, Italy, Portugal, Spain, Sweden, and the Netherlands).
Monkeypox (MPX) does not spread easily between people. Human-to-human transmission occurs through close contact ...
Although Shiga toxin-producing Escherichia coli (STEC) have been isolated from a variety of food production animals, they are most commonly associated with ruminants from which we derive meat and milk. Because of the widespread and diverse nature of ruminant-derived food production, coupled with the...
The new WHO recommendations for the treatment of isoniazid-resistant, rifampicin-susceptible TB are based upon a review of evidence from patients treated with such regimens by a Guideline Development Group in conformity with WHO requirements for evidence-based policies.
Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force
• provide scientific information on the safety, efficacy, and quality control/ quality assurance of widely used medicinal plants, in order to facilitate their appropriate use in Member States;
• provide models to assist Member States in developing their own mono- graphs or formularies for these...
The present Consolidated guidelines include a comprehensive set of WHO recommendations for the treatment and care of DR-TB, derived from these WHO guidelines documents. The consolidated guidelines include policy recommendations on treatment regimens for isoniazid-resistant TB (Hr-TB) and MDR/RR-TB, ...
Improving the management of childhood tuberculosis within national tuberculosis programmes: research priorities based on a literature review
WHO/HTM/TB/2007.381, 07.02
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
This module is part of the WHO series The Immunological Basis for Immunization, which was initially developed in 1993 as a set of eight modules, comprising one module on general immunology and seven modules each devoted to one of the vaccines recommended for the Expanded Programme on Immunization, i...
Interim practical manual supporting implementation of the WHO guidelines on core components of infection prevention and control programmes
Member States have requested WHO policy guidance on how to facilitate the implementation of national AMS activities in an integrated and programmatic approach. This policy guidance responds to that demand from Member States and is anchored in public health guiding principles in the human health sect...
Guidelines for the Management and Therapy of Urinary Tract Infection and Male Genitalia in Indonesia
Recommendations for in-patient management of COVID-19 in adult patients
Version 10, November 2020.
Terminology used to describe the transmission of pathogens through the air varies across scientific disciplines, organizations and the general public. While this has been the case for decades, during the coronavirus disease (COVID-19) pandemic, the terms ‘airborne’, ‘airborne transmission’ a...
